GSK3B and urinary bladder carcinoma: In addition, studies have shown that the inhibition of GSK3β attenuates survival and proliferation and induces apoptosis in various types of cancers, such as pancreatic cancer [11], colorectal cancer [12], [15] and bladder cancer [18].